AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
This Quarter Return
+48.65%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$840M
AUM Growth
+$840M
Cap. Flow
+$42.7M
Cap. Flow %
5.08%
Top 10 Hldgs %
96.44%
Holding
16
New
1
Increased
–
Reduced
1
Closed
–

Top Buys

1
KRRO icon
Korro Bio
KRRO
$53.6M

Top Sells

1
IRON icon
Disc Medicine
IRON
$11M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
KYMR icon
1
Kymera Therapeutics
KYMR
$2.95B
$149M 17.76%
5,858,262
– –
IRON icon
2
Disc Medicine
IRON
$2.07B
$148M 17.58%
2,555,172
-190,163
-7% -$11M
DYN icon
3
Dyne Therapeutics
DYN
$1.92B
$131M 15.66%
9,885,449
– –
THRD
4
DELISTED
Third Harmonic Bio
THRD
$120M 14.25%
10,907,859
– –
DAWN icon
5
Day One Biopharmaceuticals
DAWN
$769M
$111M 13.23%
7,608,394
– –
KRRO icon
6
Korro Bio
KRRO
$217M
$53.6M 6.39%
+1,119,292
New +$53.6M
JBIO
7
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$46.1M 5.5%
2,039,249
– –
VIGL
8
DELISTED
Vigil Neuroscience
VIGL
$19.7M 2.35%
5,836,874
– –
REPL icon
9
Replimune Group
REPL
$422M
$17.7M 2.11%
2,098,300
– –
GBIO icon
10
Generation Bio
GBIO
$40.4M
$13.7M 1.63%
8,279,484
– –
IMA
11
ImageneBio, Inc. Common Stock
IMA
$150M
$9.89M 1.18%
5,018,178
– –
AKRO icon
12
Akero Therapeutics
AKRO
$3.74B
$8.39M 1%
359,251
– –
TECX
13
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$6.18M 0.74%
4,541,381
– –
DNTH icon
14
Dianthus Therapeutics
DNTH
$759M
$2.46M 0.29%
236,979
– –
XLO icon
15
Xilio Therapeutics
XLO
$36.3M
$1.52M 0.18%
2,759,344
– –
SPRO icon
16
Spero Therapeutics
SPRO
$116M
$1.49M 0.18%
1,013,438
– –